CLINICAL_TRIALS
trial_result
· 2010-02-11
Clinical Trial Update: Study of SU011248 in Patients With Advanced Kidney Cancer [Phase 2]
Summary
Pfizer's SU011248 in a Phase 2 trial for advanced renal cell carcinoma; results were posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: COMPLETED | Results posted: 2010-02-11